Three doses of HPV vaccine recommended against genital warts

February 11, 2014, Karolinska Institutet

Two doses of vaccine against human papillomavirus (HPV) provide good protection against genital warts, but three doses is better according to an extensive register study by researchers at Karolinska Institutet in Sweden. The results are published in the scientific periodical JAMA.

Since 2012, girls in Sweden between the ages of 10 and 18 are offered free vaccination against HPV. The vaccine provides protection against various types of HPV, including some that cause and those that cause . Current recommendation is three doses of the vaccine however there is an ongoing discussion about reducing to a two-dose regime. Currently there is not enough evidence whether two doses are as effective as three in terms of duration of protection.

The researchers behind the current study have taken advantage of the Swedish health care registers to study all girls and young women (between 10 and 24 years of age) in Sweden between 2006 and 2010, in more than a million individuals. The girls were divided into groups, depending on whether they were unvaccinated or had received 1, 2 or 3 doses of the Gardasil vaccine. Almost 8 out 10 of those who were vaccinated during the period received all three doses. The researchers studied the occurrence of genital warts because it is the earliest measurable prevented disease outcome for the HPV vaccine. The vaccine is primarily administered to prevent the occurrence of cervical cancer, which takes significantly longer time to develop and therefore cannot yet be studied.

In the studied population, more than 20,000 cases of genital warts were noted during the follow-up period, on average 3.8 years. There was an association between the occurrence of genital warts and the number of vaccination doses received.

"When it comes to the 's ability to protect against genital warts in girls between 10 and 16 years of age we can see that two doses provide good protection, up to 71 per cent, but that three doses is better, up to 82 per cent, " says Lisen Arnheim Dahlström at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet. "Our results suggest that we should continue with the recommended three doses, but open up for a future two-dose schedule after more studies have been conducted regarding the protection against genital warts and initial stages of cervical cancer."

Between 2007 and 2011, Swedish girls between 13 and 17 years of age were offered subsidised HPV vaccinations. From 2012 HPV vaccination is for free for girls between 10 and 18 years of age.

Explore further: Implementing HPV vaccinations at a young age is significant for vaccine effectiveness, study finds

More information: 'Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma', Eva Herweijer, Amy Leval, Alexander Ploner, Sandra Eloranta, Julia Fridman Simard, Joakim Dillner, Eva Netterlid, Pär Sparén, and Lisen Arnheim-Dahlström, JAMA, online 11 February 2014. doi:10.1001/jama.2014.95

Related Stories

Implementing HPV vaccinations at a young age is significant for vaccine effectiveness, study finds

March 13, 2013
The incidence of genital warts, or condylomata, declined by 93 per cent in girls given the HPV vaccine before the age of 14, according to a Swedish national registry study. The study was carried out by researchers at Karolinska ...

1 in 5 boys got HPV shot in first year recommended

August 29, 2013
A new report offers a first look at how many boys are getting shots designed to protect girls from cervical cancer. Health officials say the number getting vaccinated so far is a good start.

President's panel calls for more girls, boys to get HPV vaccine

February 10, 2014
(HealthDay)—Too few American girls and boys are getting vaccinated against the cancer-causing human papillomavirus (HPV), the President's Cancer Panel reported Monday.

No serious adverse reactions to HPV vaccination

October 9, 2013
Researchers at Karolinska Institutet in Sweden and their Danish colleagues have monitored HPV-vaccinated girls via patient data registries in order to examine the incidence of a wide range of diseases and thus determine if ...

Beliefs about HPV vaccine do not lead to initiation of sex or risky sexual behavior

February 3, 2014
A new study may alleviate concerns that the human papillomavirus (HPV) vaccine leads to either the initiation of sex or unsafe sexual behaviors among teenage girls and young women.

Report: Teen HPV vaccination rate still lagging

July 25, 2013
(AP)—Disappointed health officials say only about half of teenage girls have gotten a controversial vaccine against cervical cancer—a rate that's changed little in three years.

Recommended for you

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.